Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Transcriptomic and functional deficits in human TREM2-/- microglia impair response to Alzheimer's pathology in vivo [bulk RNA-seq]
PubMed Full text in PMC Similar studies SRA Run Selector
Transcriptomic and functional deficits in human TREM2-/- microglia impair response to Alzheimer's pathology in vivo
PubMed Full text in PMC Similar studies
Transcriptomic and functional deficits in human TREM2-/- microglia impair response to Alzheimer's pathology in vivo [scRNA-seq]
Transcriptomic and functional deficits in human TREM2-/- microglia impair response to Alzheimer’s pathology in vivo [RNA-seq]
PubMed Full text in PMC Similar studies Analyze with GEO2RSRA Run Selector
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases VI
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases V
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases IV
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases
PubMed Full text in PMC Similar studies Analyze with GEO2R
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases III
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases II
The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases I
Prior activation state shapes the microglia response to anti-human TREM2 in a mouse model of Alzheimer's disease
TREM2 Acts Downstream of CD33 in Modulating Microglial Pathology in Alzheimer's Disease
Trem2 effects on brain resident myeloid cells in PS2APP model
Xenografted human microglia display diverse transcriptomic states in response to Alzheimer’s disease-related Aβ pathology
Stem cell derived human microglia transplanted in mouse brain to study human disease
The major risk factors for Alzheimer’s disease: Age, Sex and Genes, modulate the microglia response to Aβ plaques
The major risk factors for Alzheimer’s disease: Age, Sex and Genes, modulate the microglia response to Aβ plaques (KW)
The major risk factors for Alzheimer’s disease: Age, Sex and Genes, modulate the microglia response to Aβ plaques (CDEP)
Expression data of iPS microglia treated with TREM2 agonist antibody
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on